GS-7340 25mg 25mg | Purity Not Available
Adooq Bioscience
GS-7340 is a prodrug of tenofovir (TFV) that more efficiently delivers TFV into lymphoid cells and tissues than TFV disoproxil fumarate.
More Information Supplier PageSearch Results
GS-7340 10mg 10mg | Purity Not Available
Adooq Bioscience
GS-7340 is a prodrug of tenofovir (TFV) that more efficiently delivers TFV into lymphoid cells and tissues than TFV disoproxil fumarate.
More Information Supplier PageOritavancin 5mg 5mg | Purity Not Available
Adooq Bioscience
Oritavancin is a novel semisynthetic glycopeptide antibiotics. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections. Oritavancin possesses potent and rapid bactericidal activity in vitro against a broad spectrum of both resistant and susceptible Gram-positive bacteria, including Staphylococcus aureus, MRSA, enterococci, and streptococci.
More Information Supplier PageOritavancin 2mg 2mg | Purity Not Available
Adooq Bioscience
Oritavancin is a novel semisynthetic glycopeptide antibiotics. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections. Oritavancin possesses potent and rapid bactericidal activity in vitro against a broad spectrum of both resistant and susceptible Gram-positive bacteria, including Staphylococcus aureus, MRSA, enterococci, and streptococci.
More Information Supplier PageOritavancin 10mg 10mg | Purity Not Available
Adooq Bioscience
Oritavancin is a novel semisynthetic glycopeptide antibiotics. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections. Oritavancin possesses potent and rapid bactericidal activity in vitro against a broad spectrum of both resistant and susceptible Gram-positive bacteria, including Staphylococcus aureus, MRSA, enterococci, and streptococci.
More Information Supplier PageUrsodeoxycholic acid 5000mg 5000mg | Purity Not Available
Adooq Bioscience
Ursodeoxycholic acid (UDCS) is a cell protectant used extensively to mitigate hepatic and biliary diseases.
More Information Supplier PageSBC-115076 50mg 50mg | Purity Not Available
Adooq Bioscience
SBC-115076 is an anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds, for the treatment and/or prevention of cardiovascular diseases.
More Information Supplier PageSBC-115076 25mg 25mg | Purity Not Available
Adooq Bioscience
SBC-115076 is an anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds, for the treatment and/or prevention of cardiovascular diseases.
More Information Supplier PageSBC-115076 10mg 10mg | Purity Not Available
Adooq Bioscience
SBC-115076 is an anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds, for the treatment and/or prevention of cardiovascular diseases.
More Information Supplier PageSU10944 2mg 2mg | Purity Not Available
Adooq Bioscience
SU10944 is a small molecule kinase inhibitor of VEGFR that inhibits neovascularization and permeability, and is distributed to the eye upon systemic delivery.
More Information Supplier Page